Copyright Reports & Markets. All rights reserved.

Global Glaucoma Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Glaucoma Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Prostaglandin Analogs (PGAs)
      • 1.4.3 Beta Blocker
      • 1.4.4 Alpha Agonist
    • 1.5 Market by Application
      • 1.5.1 Global Glaucoma Treatment Market Share by Application (2014-2025)
      • 1.5.2 Clinic
      • 1.5.3 Pharmacy
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Glaucoma Treatment Market Size
    • 2.2 Glaucoma Treatment Growth Trends by Regions
      • 2.2.1 Glaucoma Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Glaucoma Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Glaucoma Treatment Market Size by Manufacturers
      • 3.1.1 Global Glaucoma Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Glaucoma Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Glaucoma Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Glaucoma Treatment Key Players Head office and Area Served
    • 3.3 Key Players Glaucoma Treatment Product/Solution/Service
    • 3.4 Date of Enter into Glaucoma Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Glaucoma Treatment Market Size by Type (2014-2019)
    • 4.2 Global Glaucoma Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Glaucoma Treatment Market Size (2014-2019)
    • 5.2 Glaucoma Treatment Key Players in United States
    • 5.3 United States Glaucoma Treatment Market Size by Type
    • 5.4 United States Glaucoma Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Glaucoma Treatment Market Size (2014-2019)
    • 6.2 Glaucoma Treatment Key Players in Europe
    • 6.3 Europe Glaucoma Treatment Market Size by Type
    • 6.4 Europe Glaucoma Treatment Market Size by Application

    7 China

    • 7.1 China Glaucoma Treatment Market Size (2014-2019)
    • 7.2 Glaucoma Treatment Key Players in China
    • 7.3 China Glaucoma Treatment Market Size by Type
    • 7.4 China Glaucoma Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Glaucoma Treatment Market Size (2014-2019)
    • 8.2 Glaucoma Treatment Key Players in Japan
    • 8.3 Japan Glaucoma Treatment Market Size by Type
    • 8.4 Japan Glaucoma Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Glaucoma Treatment Market Size (2014-2019)
    • 9.2 Glaucoma Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Glaucoma Treatment Market Size by Type
    • 9.4 Southeast Asia Glaucoma Treatment Market Size by Application

    10 India

    • 10.1 India Glaucoma Treatment Market Size (2014-2019)
    • 10.2 Glaucoma Treatment Key Players in India
    • 10.3 India Glaucoma Treatment Market Size by Type
    • 10.4 India Glaucoma Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Glaucoma Treatment Market Size (2014-2019)
    • 11.2 Glaucoma Treatment Key Players in Central & South America
    • 11.3 Central & South America Glaucoma Treatment Market Size by Type
    • 11.4 Central & South America Glaucoma Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Novartis
      • 12.1.1 Novartis Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Glaucoma Treatment Introduction
      • 12.1.4 Novartis Revenue in Glaucoma Treatment Business (2014-2019)
      • 12.1.5 Novartis Recent Development
    • 12.2 Allergan
      • 12.2.1 Allergan Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Glaucoma Treatment Introduction
      • 12.2.4 Allergan Revenue in Glaucoma Treatment Business (2014-2019)
      • 12.2.5 Allergan Recent Development
    • 12.3 Pfizer
      • 12.3.1 Pfizer Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Glaucoma Treatment Introduction
      • 12.3.4 Pfizer Revenue in Glaucoma Treatment Business (2014-2019)
      • 12.3.5 Pfizer Recent Development
    • 12.4 Akorn
      • 12.4.1 Akorn Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Glaucoma Treatment Introduction
      • 12.4.4 Akorn Revenue in Glaucoma Treatment Business (2014-2019)
      • 12.4.5 Akorn Recent Development
    • 12.5 Teva
      • 12.5.1 Teva Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Glaucoma Treatment Introduction
      • 12.5.4 Teva Revenue in Glaucoma Treatment Business (2014-2019)
      • 12.5.5 Teva Recent Development
    • 12.6 Bausch & Lomb
      • 12.6.1 Bausch & Lomb Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Glaucoma Treatment Introduction
      • 12.6.4 Bausch & Lomb Revenue in Glaucoma Treatment Business (2014-2019)
      • 12.6.5 Bausch & Lomb Recent Development
    • 12.7 Otsuka Pharmaceutical
      • 12.7.1 Otsuka Pharmaceutical Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Glaucoma Treatment Introduction
      • 12.7.4 Otsuka Pharmaceutical Revenue in Glaucoma Treatment Business (2014-2019)
      • 12.7.5 Otsuka Pharmaceutical Recent Development
    • 12.8 Santen
      • 12.8.1 Santen Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Glaucoma Treatment Introduction
      • 12.8.4 Santen Revenue in Glaucoma Treatment Business (2014-2019)
      • 12.8.5 Santen Recent Development
    • 12.9 Lunan Pharma
      • 12.9.1 Lunan Pharma Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Glaucoma Treatment Introduction
      • 12.9.4 Lunan Pharma Revenue in Glaucoma Treatment Business (2014-2019)
      • 12.9.5 Lunan Pharma Recent Development
    • 12.10 Zizhu Pharma
      • 12.10.1 Zizhu Pharma Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Glaucoma Treatment Introduction
      • 12.10.4 Zizhu Pharma Revenue in Glaucoma Treatment Business (2014-2019)
      • 12.10.5 Zizhu Pharma Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Glaucoma can be treated with eye drops, pills, laser surgery, traditional surgery or a combination of these methods. The goal of any treatment is to prevent loss of vision, as vision loss from glaucoma is irreversible.
      In the last several years, Hong Kong market of Glaucoma Treatment developed rapidly, with an average growth rate of 4% during 2013 to 2018. In 2018, Hong Kong revenue of Glaucoma Treatment is nearly 73 M USD.
      The classification of Glaucoma Treatment includes Prostaglandin Analogs (PGAs), Beta Blocker, Alpha Agonist and other, and the proportion of Prostaglandin Analogs (PGAs) in 2018 is about 52%, and the proportion is in increasing trend from 2013 to 2018.
      Glaucoma Treatment is widely used in Clinic, Pharmacy and other field. The most proportion of Glaucoma Treatment is in hospitals, and the proportion in 2018 is 66%.
      In 2018, the global Glaucoma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Glaucoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Glaucoma Treatment development in United States, Europe and China.

      The key players covered in this study
      Novartis
      Allergan
      Pfizer
      Akorn
      Teva
      Bausch & Lomb
      Otsuka Pharmaceutical
      Santen
      Lunan Pharma
      Zizhu Pharma

      Market segment by Type, the product can be split into
      Prostaglandin Analogs (PGAs)
      Beta Blocker
      Alpha Agonist

      Market segment by Application, split into
      Clinic
      Pharmacy
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Glaucoma Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Glaucoma Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Glaucoma Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now